Clinical Trial Update: Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B [Phase 4]

View source ↗

Summary

Phase 4 clinical trial in late pregnancy evaluated telbivudine and lamivudine to prevent vertical transmission of hepatitis B; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Epivir-HBV (lamivudine)
• Tyzeka (telbivudine)

Snippet

Sponsor: Beijing YouAn Hospital | Conditions: Chronic Hepatitis B, Late Pregnancy | Phase 4 | Status: COMPLETED